156 related articles for article (PubMed ID: 37628931)
21. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
[TBL] [Abstract][Full Text] [Related]
22. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
[TBL] [Abstract][Full Text] [Related]
23. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
[TBL] [Abstract][Full Text] [Related]
24. In situ surface-enhanced Raman scattering spectroscopy exploring molecular changes of drug-treated cancer cell nucleus.
Liang L; Huang D; Wang H; Li H; Xu S; Chang Y; Li H; Yang YW; Liang C; Xu W
Anal Chem; 2015 Feb; 87(4):2504-10. PubMed ID: 25602628
[TBL] [Abstract][Full Text] [Related]
25. Intracellular dynamics of topoisomerase I inhibitor, CPT-11, by slit-scanning confocal Raman microscopy.
Harada Y; Dai P; Yamaoka Y; Ogawa M; Tanaka H; Nosaka K; Akaji K; Takamatsu T
Histochem Cell Biol; 2009 Jul; 132(1):39-46. PubMed ID: 19365636
[TBL] [Abstract][Full Text] [Related]
26. Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via
Gao Y; Hai L; Kang Y; Qin W; Liu F; Cai R; Yang X; Qi Y
Front Pharmacol; 2021; 12():768643. PubMed ID: 34690789
[TBL] [Abstract][Full Text] [Related]
27. Network Pharmacological Study of Compound Kushen Injection in Esophageal Cancer.
Guo D; Jin J; Liu J; Ren M; He Y
Curr Comput Aided Drug Des; 2023; 19(5):367-381. PubMed ID: 36635923
[TBL] [Abstract][Full Text] [Related]
28. Intracellular investigation on the differential effects of 4 polyphenols on MCF-7 breast cancer cells by Raman imaging.
Mignolet A; Wood BR; Goormaghtigh E
Analyst; 2017 Dec; 143(1):258-269. PubMed ID: 29214243
[TBL] [Abstract][Full Text] [Related]
29. The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms.
Cui J; Qu Z; Harata-Lee Y; Shen H; Aung TN; Wang W; Kortschak RD; Adelson DL
PLoS One; 2020; 15(7):e0236395. PubMed ID: 32730293
[TBL] [Abstract][Full Text] [Related]
30. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
Front Oncol; 2022; 12():946758. PubMed ID: 36016606
[TBL] [Abstract][Full Text] [Related]
31. Multivariate Analysis of Difference Raman Spectra of the Irradiated Nucleus and Cytoplasm Region of SH-SY5Y Human Neuroblastoma Cells.
Delfino I; Ricciardi V; Manti L; Lasalvia M; Lepore M
Sensors (Basel); 2019 Sep; 19(18):. PubMed ID: 31540064
[TBL] [Abstract][Full Text] [Related]
32. Exploring subcellular responses of prostate cancer cells to X-ray exposure by Raman mapping.
Roman M; Wrobel TP; Panek A; Efeoglu E; Wiltowska-Zuber J; Paluszkiewicz C; Byrne HJ; Kwiatek WM
Sci Rep; 2019 Jun; 9(1):8715. PubMed ID: 31213635
[TBL] [Abstract][Full Text] [Related]
33. [Anti-tumor and analgesic activity evaluation and mechanism of Compound Kushen Injection].
Fan QQ; She GM; Wei J; Li ZQ; Chen ML; Dong Y; Yu AX; Li JW; Qin WJ; Wang W; Lin RC; Zhao CJ; You RL
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2712-2720. PubMed ID: 35718491
[TBL] [Abstract][Full Text] [Related]
34. Compound Kushen Injection Protects Skin From Radiation Injury
Zheng J; Li G; Wang J; Wang S; Tang Q; Sheng H; Wu W; Wang S
Front Pharmacol; 2021; 12():753068. PubMed ID: 34955827
[No Abstract] [Full Text] [Related]
35. In vitro monitoring of time and dose dependent cytotoxicity of aminated nanoparticles using Raman spectroscopy.
Efeoglu E; Casey A; Byrne HJ
Analyst; 2016 Sep; 141(18):5417-31. PubMed ID: 27373561
[TBL] [Abstract][Full Text] [Related]
36. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
Liang S; Li Y; Zhang X; Guo Y; Pan S
Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
[TBL] [Abstract][Full Text] [Related]
37. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
[TBL] [Abstract][Full Text] [Related]
38. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
39. An Advanced Systems Pharmacology Strategy Reveals
Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
[TBL] [Abstract][Full Text] [Related]
40. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
